Abbott Laboratories (ABT) Stock

About Abbott Laboratories

Abbott Laboratories is led by CEO Robert Ford, employs 114,000 people, headquartered in Abbott Park, US, publicly traded since 1980.

Abbott Laboratories (ABT) stock trades at $98.49 with a market capitalization of $170.43B. The stock is valued at a price-to-earnings (P/E) ratio of 32.57, price-to-book of 3.45, price-to-sales of 3.76. Over the past 52 weeks the stock has ranged between $81.97 and $135.45, and currently trades 27.3% below its 52-week high. It pays a dividend yielding 2.49%.

On profitability, Abbott Laboratories generates a return on equity (ROE) of 10.52%, return on capital employed of 8.68%, an operating margin of 18.17%, a net profit margin of 11.65%.

In its most recent fiscal year, Abbott Laboratories reported annual revenue of $44.3B, net profit of $6.5B, revenue has compounded at 5.1% a year over the last five years, profit at 7.7% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.64, a current ratio of 1.58, total assets of $86.7B, $8.5B in cash and equivalents.

ABT has a beta of 0.59 (less volatile than the overall market).